Cerus Corporation (CERS) Financial Statements (2024 and earlier)
Company Profile
Business Address |
1220 CONCORD AVENUE CONCORD, CA 94520 |
State of Incorp. | DE |
Fiscal Year End | December 31 |
Industry (SIC) | 3841 - Surgical and Medical Instruments and Apparatus (benchmarking) |
More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)Annual | Quarterly
9/30/2023 Q3 | 6/30/2023 Q2 | 3/31/2023 Q1 | 12/31/2022 Q4 | 9/30/2022 Q3 | 6/30/2022 Q2 | 3/31/2022 Q1 | |||
---|---|---|---|---|---|---|---|---|---|
ASSETS | |||||||||
Current Assets | |||||||||
Cash, cash equivalents, and short-term investments | 84,503 | 94,680 | 102,154 | 103,827 | 107,047 | 108,557 | |||
Cash and cash equivalents | 20,635 | 27,604 | 35,585 | 28,875 | 32,309 | 38,372 | |||
Short-term investments | 63,868 | 67,076 | 66,569 | 74,952 | 74,738 | 70,185 | |||
Receivables | 22,175 | 25,242 | 34,426 | 28,151 | 26,837 | 25,645 | |||
Inventory, net of allowances, customer advances and progress billings | 40,608 | 36,614 | 29,003 | 28,329 | 27,758 | 28,521 | |||
Inventory | 40,608 | 36,614 | 29,003 | 28,329 | 27,758 | 28,521 | |||
Other undisclosed current assets | 3,650 | 5,680 | 4,561 | 4,424 | 3,030 | 10,089 | |||
Total current assets: | 150,936 | 162,216 | 170,144 | 164,731 | 164,672 | 172,812 | |||
Noncurrent Assets | |||||||||
Inventory, Noncurrent | |||||||||
Operating lease, right-of-use asset | 12,268 | 12,313 | 12,512 | 12,890 | 13,259 | 13,665 | |||
Property, plant and equipment | 10,254 | 10,831 | 10,969 | 10,647 | 11,201 | 11,659 | |||
Intangible assets, net (including goodwill) | 1,316 | 1,316 | 1,316 | 1,316 | 1,316 | 1,316 | |||
Goodwill | 1,316 | 1,316 | 1,316 | 1,316 | 1,316 | 1,316 | |||
Restricted cash and investments | 1,793 | 1,785 | 1,773 | 1,998 | 2,014 | 2,003 | |||
Other noncurrent assets | 22,293 | 20,875 | 21,378 | 23,821 | 23,994 | 20,451 | |||
Total noncurrent assets: | 47,924 | 47,120 | 47,948 | 50,672 | 51,784 | 49,094 | |||
TOTAL ASSETS: | 198,860 | 209,336 | 218,092 | 215,403 | 216,456 | 221,906 | |||
LIABILITIES AND EQUITY | |||||||||
Liabilities | |||||||||
Current Liabilities | |||||||||
Accounts payable and accrued liabilities | 54,999 | 55,723 | 58,205 | 63,552 | 47,630 | 48,422 | |||
Employee-related liabilities | ✕ | ✕ | ✕ | ✕ | 13,678 | ✕ | ✕ | ||
Accounts payable | 37,489 | 36,436 | 33,002 | 29,815 | 29,355 | 31,474 | |||
Accrued liabilities | 17,510 | 19,287 | 25,203 | 20,059 | 18,275 | 16,948 | |||
Deferred revenue | 1,361 | 1,693 | 589 | 754 | 975 | 1,258 | |||
Debt | 16,542 | 18,000 | 56,159 | 42,380 | 28,680 | 15,011 | |||
Restructuring reserve | 856 | ||||||||
Other undisclosed current liabilities | 1,320 | 2,157 | 2,105 | (11,667) | 1,994 | 1,968 | |||
Total current liabilities: | 75,078 | 77,573 | 117,058 | 95,019 | 79,279 | 66,659 | |||
Noncurrent Liabilities | |||||||||
Long-term debt and lease obligation | 54,838 | 54,827 | 13,644 | 43,060 | 57,286 | 71,556 | |||
Long-term debt, excluding current maturities | 54,838 | 54,827 | 13,644 | 27,357 | 41,065 | 54,769 | |||
Liabilities, other than long-term debt | 17,254 | 17,374 | 18,828 | 3,251 | 3,130 | 3,280 | |||
Other liabilities | 2,800 | 2,414 | 3,499 | 3,251 | 3,130 | 3,280 | |||
Operating lease, liability | 14,454 | 14,960 | 15,329 | 15,703 | 16,221 | 16,787 | |||
Total noncurrent liabilities: | 72,092 | 72,201 | 32,472 | 46,311 | 60,416 | 74,836 | |||
Total liabilities: | 147,170 | 149,774 | 149,530 | 141,330 | 139,695 | 141,495 | |||
Equity | |||||||||
Equity, attributable to parent | 50,816 | 58,632 | 67,610 | 73,120 | 75,769 | 79,413 | |||
Common stock | 181 | 180 | 177 | 177 | 177 | 177 | |||
Additional paid in capital | 1,089,083 | 1,083,433 | 1,077,341 | 1,069,629 | 1,062,760 | 1,057,497 | |||
Accumulated other comprehensive loss | (2,433) | (2,241) | (2,787) | (3,189) | (2,153) | (1,635) | |||
Accumulated deficit | (1,036,015) | (1,022,740) | (1,007,121) | (993,497) | (985,015) | (976,626) | |||
Equity, attributable to noncontrolling interest | 874 | 930 | 952 | 953 | 992 | 998 | |||
Total equity: | 51,690 | 59,562 | 68,562 | 74,073 | 76,761 | 80,411 | |||
TOTAL LIABILITIES AND EQUITY: | 198,860 | 209,336 | 218,092 | 215,403 | 216,456 | 221,906 |
Income Statement (P&L) ($ in thousands)Annual | Quarterly
9/30/2023 Q3 | 6/30/2023 Q2 | 3/31/2023 Q1 | 12/31/2022 Q4 | 9/30/2022 Q3 | 6/30/2022 Q2 | 3/31/2022 Q1 | ||
---|---|---|---|---|---|---|---|---|
Revenues | 188,315 | |||||||
Operating expenses | (41,853) | (38,935) | (41,774) | (36,128) | (34,748) | (34,792) | ||
Other undisclosed operating income | 30,213 | 24,789 | 31,823 | 28,681 | 27,913 | 24,944 | ||
Operating loss: | (11,640) | (14,146) | (9,951) | (7,447) | (6,835) | (9,848) | ||
Nonoperating expense | (1,593) | (1,418) | (3,407) | (1,007) | (1,482) | (2,360) | ||
Gain (loss), foreign currency transaction, before tax | 49 | (193) | (622) | 234 | (104) | (198) | ||
Other nonoperating income (expense) | 539 | 387 | (1,088) | 165 | (30) | (782) | ||
Interest and debt expense | (2,181) | (1,612) | (1,697) | (1,406) | (1,348) | (1,380) | ||
Loss from continuing operations before equity method investments, income taxes: | (15,414) | (17,176) | (15,055) | (9,860) | (9,665) | (13,588) | ||
Other undisclosed income from continuing operations before income taxes | 2,181 | 1,612 | 1,697 | 1,406 | 1,348 | 1,380 | ||
Loss from continuing operations before income taxes: | (13,233) | (15,564) | (13,358) | (8,454) | (8,317) | (12,208) | ||
Income tax expense | (98) | (77) | (267) | (67) | (78) | (76) | ||
Loss from continuing operations: | (13,331) | (15,641) | (13,625) | (8,521) | (8,395) | (12,284) | ||
Loss before gain (loss) on sale of properties: | ✕ | ✕ | ✕ | ✕ | (8,521) | (8,395) | (12,284) | |
Net loss: | (13,331) | (15,641) | (13,625) | (8,521) | (8,395) | (12,284) | ||
Net income attributable to noncontrolling interest | 56 | 22 | 1 | 39 | 6 | |||
Net loss available to common stockholders, diluted: | (13,275) | (15,619) | (13,624) | (8,482) | (8,389) | (12,284) |
Comprehensive Income ($ in thousands)Annual | Quarterly
9/30/2023 Q3 | 6/30/2023 Q2 | 3/31/2023 Q1 | 12/31/2022 Q4 | 9/30/2022 Q3 | 6/30/2022 Q2 | 3/31/2022 Q1 | ||
---|---|---|---|---|---|---|---|---|
Net loss: | (13,331) | (15,641) | (13,625) | (8,521) | (8,395) | (12,284) | ||
Other comprehensive income (loss) | (192) | 546 | (1,036) | (518) | (1,486) | |||
Other undisclosed comprehensive income | 402 | |||||||
Comprehensive loss: | (13,523) | (15,095) | (13,223) | (9,557) | (8,913) | (13,770) | ||
Comprehensive income, net of tax, attributable to noncontrolling interest | 56 | 22 | 1 | 39 | 6 | |||
Comprehensive loss, net of tax, attributable to parent: | (13,467) | (15,073) | (13,222) | (9,518) | (8,907) | (13,770) |
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.